DaVita, Inc. (DVA) Tops Q4 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Goldman Sachs Downgrades DaVita (DVA) to Neutral
February 15, 2013 6:57 AM ESTGoldman Sachs downgraded DaVita (NYSE: DVA) from Buy to Neutral with a price target of $120 saying the stock is fairly valued and they see more upside elsewhere.
"While our outlook for core dialysis remains solid and we continue to see strong long-term growth... More



